Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Puccetti

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Critical Reviews in Immunology|June 14, 2003
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunityPaolo Puccetti, Maria L Belladonna, Ursula Grohmann
Trends in Molecular Medicine|September 22, 2018
Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune DiabetesCiriana Orabona, Giada Mondanelli, Paolo Puccetti, et al.
Trends in Molecular Medicine|January 24, 2009
TGF-beta and kynurenines as the key to infectious toleranceMaria L Belladonna, Ciriana Orabona, Ursula Grohmann, et al.
International Journal of Molecular Sciences|April 30, 2021
Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor ImmunotherapyMarco Gargaro, Giorgia Manni, Giulia Scalisi, et al.
Microbes and Infection|November 15, 2008
Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the hostTeresa Zelante, Francesca Fallarino, Francesco Bistoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
IL-17 and therapeutic kynurenines in pathogenic inflammation to fungiLuigina Romani, Teresa Zelante, Antonella De Luca, et al.
Expert Opinion on Drug Discovery|August 8, 2019
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosisClaudia Volpi, Ciriana Orabona, Antonio Macchiarulo, et al.
Frontiers in Medicine|June 21, 2024
Phenotypic drug discovery: a case for thymosin alpha-1Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Trends in Endocrinology and Metabolism: TEM|August 14, 2024
Host-microbe serotonin metabolismEmilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Blood|June 14, 2012
Clotting factor concentrate switching and inhibitor development in hemophilia AAlfonso Iorio, Paolo Puccetti, Mike Makris
Critical Reviews in Immunology|June 14, 2003
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunityPaolo Puccetti, Maria L Belladonna, Ursula Grohmann
Trends in Molecular Medicine|September 22, 2018
Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune DiabetesCiriana Orabona, Giada Mondanelli, Paolo Puccetti, et al.
Trends in Molecular Medicine|January 24, 2009
TGF-beta and kynurenines as the key to infectious toleranceMaria L Belladonna, Ciriana Orabona, Ursula Grohmann, et al.
International Journal of Molecular Sciences|April 30, 2021
Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor ImmunotherapyMarco Gargaro, Giorgia Manni, Giulia Scalisi, et al.
Microbes and Infection|November 15, 2008
Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the hostTeresa Zelante, Francesca Fallarino, Francesco Bistoni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2008
IL-17 and therapeutic kynurenines in pathogenic inflammation to fungiLuigina Romani, Teresa Zelante, Antonella De Luca, et al.
Expert Opinion on Drug Discovery|August 8, 2019
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosisClaudia Volpi, Ciriana Orabona, Antonio Macchiarulo, et al.
Frontiers in Medicine|June 21, 2024
Phenotypic drug discovery: a case for thymosin alpha-1Enrico Garaci, Maurizio Paci, Claudia Matteucci, et al.
Trends in Endocrinology and Metabolism: TEM|August 14, 2024
Host-microbe serotonin metabolismEmilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Pageof 12